Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.

Int J Biol Sci · 2022 · PMC8898375 · PMID 35280674

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

However, hepatic AdipoR2 levels were increased in HFD-fed mice and showed a decreasing trend in ATL III-treated mice but didn't reach statistical significance.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.